NXRT (NexPoint Residential Trust) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


NXRT NexPoint Residential Trust Inc NXRT
70 GF Score
Price $27.33
GF Value $33.89
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is NexPoint Residential Trust Research & Development?

NexPoint Residential Trust NXRT -1.44% 70 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates NXRT with a GF Score™ of 70/100 and a GF Value™ of $33.89 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. NexPoint Residential Trust's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.


NexPoint Residential Trust  (NYSE:NXRT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


NexPoint Residential Trust Research & Development Related Terms


NexPoint Residential Trust Research & Development Historical Data

* Premium members only.

The historical data trend for NexPoint Residential Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NexPoint Residential Trust Research & Development Chart

NexPoint Residential Trust Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NexPoint Residential Trust Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NXRT
70GF Score
NexPoint Residential Trust Inc NXRT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NexPoint Residential Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
NexPoint Residential Trust (NXRT) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on NexPoint Residential Trust and its competitors.
Is NexPoint Residential Trust's Research & Development too high?
NexPoint Residential Trust's current Research & Development is $0.0 Mil. Overall, NexPoint Residential Trust has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NexPoint Residential Trust's Research & Development compare to AIV and CSR?
NexPoint Residential Trust's Research & Development of $0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on NexPoint Residential Trust and its competitors. NexPoint Residential Trust's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexPoint Residential Trust stock overvalued right now?
Based on GuruFocus' analysis, NexPoint Residential Trust (NXRT) is currently considered Modestly Undervalued. The stock's GF Value™ is $33.89, compared to a current price of $27.33 — trading 19.4% below its estimated fair value. The current Research & Development is $0.0 Mil. NexPoint Residential Trust's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For NexPoint Residential Trust (NXRT), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NexPoint Residential Trust (NXRT) Overvalued in 2026?

Based on GuruFocus' analysis, NexPoint Residential Trust stock appears to be undervalued. The current stock price of $27.33 is trading 19.4% below its estimated GF Value™ of $33.89. GuruFocus considers NexPoint Residential Trust to be Modestly Undervalued.

Key valuation signals for NXRT:

  • Research & Development: $0.0 Mil
  • GF Value™: $33.89 vs. price of $27.33 (19.4% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the NXRT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NexPoint Residential Trust Business Description

Industry Real EstateREITs
Other Exchanges 5O4:Germany
Address 300 Crescent Court, Suite 700, Dallas, TX, USA, 75201
NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
70GF Score

Get the complete analysis for NXRT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.33
Price
$33.89
GF Value